Dr. A. Keirens
ActiveSummary
Dr. A. Keirens has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €345,417 and a net result of €117,123. Equity is shrinking by about 4.2% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
26-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
07-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Highest result from 2018 to 2025net €129,895 ▲128%
Operating result €181,389, net result €129,895, both a record.
11-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 11 days late
2022
31-12
Financial
Liquidity doublescurrent ratio 6.48
Current ratio from 3.22 to 6.48; short-term debt falls from €106,941 to €53,390.
28-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Weakest financial yearnet €16,822 ▼72.2%
Net result drops to €16,822, the lowest in the series; recovery starts the following year.
29-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
27-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
25-07
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
27-07
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
30-06
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 18 annual accounts filed, the latest 10 are here; all 18 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.